Skip to content
Subscriber Only

Johnson & Johnson Covid-19 Vaccine Cleared for Use in U.S.

  • Single-dose vaccine expands U.S. immunization arsenal
  • Shot seen as easier to distribute, administer than rivals
Bloomberg business news
Watch: White House officials say Johnson & Johnson will ship 3.9 million doses of its vaccine after it was approved for use in the U.S. over the weekend. (Source: Bloomberg)
Updated on

We're tracking the latest on the coronavirus outbreak and the global response. Sign up here for our daily newsletter on what you need to know.

Johnson & Johnson’s coronavirus vaccine was cleared for use in the U.S., making a third shot available that could plug gaps in the nation’s immunization campaign as concern grows over an influx of virus variants.